Integrase Inhibitor Prodrugs: Approaches to Enhancing the Anti-HIV Activity of β-Diketo Acids (Q26800036)

24 October 2022

Integrase Inhibitor Prodrugs: Approaches to Enhancing the Anti-HIV Activity of β-Diketo Acids (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6332332&resulttype=core&format=json

13 May 2020

main subject

HIV integrase

1 reference

HIV integrase inhibitors

1 reference

HIV type 1

1 reference

keto acid

1 reference

prodrug

1 reference

Vasu Nair

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6332332&resulttype=core&format=json

13 May 2020

Maurice Okello

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6332332&resulttype=core&format=json

object of statement has role

13 May 2020

group of authors

authors of subject

1 reference

language of work or name

English

0 references

publication date

2015

0 references

13 July 2015

1 reference

24 October 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6332332&resulttype=core&format=json

13 May 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6332332&resulttype=core&format=json

13 May 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6332332&resulttype=core&format=json

13 May 2020

page(s)

12623-12651

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6332332&resulttype=core&format=json

Creative Commons Attribution 4.0 International

13 May 2020

1 reference

24 October 2022

1 reference

describes a project that uses

ImageQuant

object named as

ImageQuant

1 reference

CZ Software Mentions: A large dataset of software mentions in the biomedical literature

cites work

HIV-1: fifteen proteins and an RNA

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

HIV integrase inhibitors as therapeutic agents in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

HIV integrase inhibitors with nucleobase scaffolds: discovery of a highly potent anti-HIV agent

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Integrase inhibitors to treat HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Quantitative prediction of human clearance guiding the development of Raltegravir (MK-0518, isentress) and related HIV integrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Pharmacokinetics and safety of S/GSK1349572, a next-generation HIV integrase inhibitor, in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Authentic HIV-1 integrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Retroviral intasome assembly and inhibition of DNA strand transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

HIV integrase as a target for antiviral chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

The role of drug transporters in the kidney: lessons from tenofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

A cutting-edge view on the current state of antiviral drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Prodrug strategies for improved efficacy of nucleoside antiviral inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

HIV treatment 2020: what will it look like?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Discovery of MK-8970: an acetal carbonate prodrug of raltegravir with enhanced colonic absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

New approaches toward anti-HIV chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

4-Aryl-2,4-dioxobutanoic acid inhibitors of HIV-1 integrase and viral replication in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Structural determinants for HIV-1 integrase inhibition by beta-diketo acids

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

New class of HIV integrase inhibitors that block viral replication in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Inhibition of human immunodeficiency virus type 1 integration by diketo derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Structure activity of 3-aryl-1,3-diketo-containing compounds as HIV-1 integrase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

HIV-1 IN strand transfer chelating inhibitors: a focus on metal binding

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Metal-dependent inhibition of HIV-1 integrase by beta-diketo acids and resistance of the soluble double-mutant (F185K/C280S).

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Diketoacid inhibitors of HIV-1 integrase: from L-708,906 to raltegravir and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Binding modes of diketo-acid inhibitors of HIV-1 integrase: a comparative molecular dynamics simulation study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Specific inhibition of human immunodeficiency virus type 1 (HIV-1) integration in cell culture: putative inhibitors of HIV-1 integrase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Enzymology of a carbonyl reduction clearance pathway for the HIV integrase inhibitor, S-1360: role of human liver cytosolic aldo-keto reductases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Azido-containing aryl beta-diketo acid HIV-1 integrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

6-aryl-2,4-dioxo-5-hexenoic acids, novel integrase inhibitors active against HIV-1 multiplication in cell-based assays

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities, and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Rational design and synthesis of novel dimeric diketoacid-containing inhibitors of HIV-1 integrase: implication for binding to two metal ions on the active site of integrase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Novel dimeric aryldiketo containing inhibitors of HIV-1 integrase: effects of the phenyl substituent and the linker orientation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

A novel diketo phosphonic acid that exhibits specific, strand-transfer inhibition of HIV integrase and anti-HIV activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Beta-diketo acids with purine nucleobase scaffolds: novel, selective inhibitors of the strand transfer step of HIV integrase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Discovery of a Potent HIV Integrase Inhibitor that Leads to a Prodrug with Significant anti-HIV Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

The strength of weak interactions: aromatic fluorine in drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

3′-Processing and strand transfer catalysed by retroviral integrasein crystallo

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Novel approaches to functionalized nucleosides via palladium-catalyzed cross coupling with organostannanes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Highly efficient preparation of aryl beta-diketo acids with tert-butyl methyl oxalate

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

A novel strategy to assemble the beta-diketo acid pharmacophore of HIV integrase inhibitors on purine nucleobase scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

A novel anti-HIV active integrase inhibitor with a favorable in vitro cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferase metabolism profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

A selective method for the direct conversion of aldehydes into .beta.-keto esters with ethyl diazoacetate catalyzed by tin(II) chloride

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200712623

HIV integrase structure and function.

21 January 2018

1 reference

12 December 2020

HIV-1 integrase: structural organization, conformational changes, and catalysis

1 reference

12 December 2020

S-1360 Shionogi-GlaxoSmithKline.

1 reference

12 December 2020

Novel Inhibitors of HIV Integrase: The Discovery of Potential Anti-HIV Therapeutic Agents

1 reference

12 December 2020

Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development.

1 reference

12 December 2020

Novel HIV integrase inhibitors with anti-HIV activity: insights into integrase inhibition from docking studies

1 reference

12 December 2020

Elvitegravir, an oral HIV integrase inhibitor, for the potential treatment of HIV infection.

1 reference

12 December 2020

Retroviral integrase : a novel target in antiviral drug development and basic in vitro assays with the purified enzyme

1 reference

12 December 2020

Novel and Potent Adenosine 3',5'-Cyclic Phosphate Phosphodiesterase III Inhibitors: Thiazolo[4,5-b][1,6]naphthyridin-2-ones

1 reference

12 December 2020

Probing interactions between viral DNA and human immunodeficiency virus type 1 integrase using dinucleotides.

1 reference

12 December 2020

In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse.

1 reference

12 December 2020

10.3390/MOLECULES200712623

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6332332&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6332332&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6332332&resulttype=core&format=json